Sophisticated analytical technologies are complementing traditional approaches in the identification of residual process-related impurities of biotherapeutics.
Stuart Pengelley
Advertisement
Stuart Pengelley is the senior scientist, Biopharma Application Development for Bruker Daltonics.
Articles by Stuart Pengelley
Advertisement
Latest Updated Articles
Advertisement
Advertisement